Viewing Study NCT02574533


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-03-11 @ 3:41 PM
Study NCT ID: NCT02574533
Status: COMPLETED
Last Update Posted: 2017-09-27
First Post: 2015-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study of Vigilâ„¢ + Pembrolizumab for Advanced Melanoma
Sponsor: Gradalis, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module